Cell & Gene Therapy for Cancer
Part of Healthcare - Oncology
| Ticker | Company | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|
 GILD | Gilead Sciences Inc | $169.2b | $139.55 | -0.1% | 559.7K |
 ACLX | Arcellx, Inc. Common Stock | $6.7b | $114.80 | +0.0% | 227.8K |
 NTLA | Intellia Therapeutics, Inc | $1.4b | $13.54 | +3.1% | 674.4K |
 IOVA | Iovance Biotherapeutics, Inc. Common Stock | $1.4b | $3.37 | -1.9% | 3.4M |
 IMTX | Immatics N.V. Ordinary Shares | $1.2b | $10.46 | +1.0% | 106.8K |
 SANA | Sana Biotechnology, Inc. Common Stock | $0.7b | $3.31 | +3.3% | 576.1K |
 VOR | Vor Biopharma Inc. Common Stock | $0.6b | $17.00 | -5.8% | 423.0K |
 YDES | YD Bio Limited Ordinary Shares | $0.6b | $7.41 | -0.3% | 7.6K |
 ALLO | Allogene Therapeutics, Inc. Common Stock | $0.5b | $2.63 | +6.3% | 935.3K |
 IMMX | Immix Biopharma, Inc. Common Stock | $454.4m | $9.11 | +1.9% | 96.9K |
 LYEL | Lyell Immunopharma, Inc. Common Stock | $449.6m | $22.18 | +4.6% | 15.9K |
 ENGN | enGene Holdings Inc. Common Stock | $414.0m | $6.96 | +4.0% | 43.2K |
 IPSC | Century Therapeutics, Inc. Common Stock | $364.8m | $2.27 | +6.8% | 171.3K |
 CRBU | Caribou Biosciences, Inc. Common Stock | $166.2m | $1.99 | +2.3% | 250.0K |
 NKTX | Nkarta, Inc. Common Stock | $142.6m | $2.40 | +3.2% | 159.3K |
 ARTV | Artiva Biotherapeutics, Inc. Common Stock | $134.7m | $7.24 | +7.4% | 186.1K |
 FATE | Fate Therapeutics, Inc. | $131.4m | $1.24 | +1.2% | 362.1K |
 ANIX | Anixa Biosciences, Inc. | $83.8m | $2.61 | +2.2% | 19.8K |
 COEP | Coeptis Therapeutics Holdings Inc. Common Stock | $66.7m | $12.15 | +1.5% | 28.6K |
 ACET | Adicet Bio, Inc. Common Stock | $58.6m | $6.90 | -1.3% | 36.5K |
 TCRX | TScan Therapeutics, Inc. Common Stock | $53.5m | $1.05 | +4.5% | 309.4K |
 INKT | MiNK Therapeutics, Inc. Common Stock | $49.4m | $12.04 | +12.6% | 53.0K |
 ESLA | Estrella Immunopharma, Inc. Common Stock | $43.9m | $1.29 | +22.9% | 116.9K |
 CELU | Celularity Inc. Class A Common Stock | $36.3m | $1.42 | +6.8% | 27.0K |
 ATRA | Atara Biotherapeutics, Inc | $35.3m | $4.97 | -0.3% | 11.8K |
 SNTI | Senti Biosciences, Inc. Common Stock | $24.0m | $0.89 | +3.4% | 20.1K |
 TVGN | Tevogen Bio Holdings Inc. Common Stock | $17.4m | $4.62 | +3.5% | 9.6K |
 INAB | IN8bio, Inc. Common Stock | $13.5m | $1.49 | +3.5% | 27.7K |
 GDTC | CytoMed Therapeutics Limited Ordinary Shares | $12.1m | $0.98 | -1.2% | 5.2K |
 LNAI | Lunai Bioworks Inc. Common Stock | $10.0m | $0.32 | -13.7% | 1.4M |
 PMCB | PharmaCyte Biotech, Inc. Common Stock | $7.2m | $0.73 | +6.2% | 67.0K |
 ERNA | Ernexa Therapeutics Inc. Common Stock | $5.5m | $0.20 | +1.2% | 166.7K |
 MBIO | Mustang Bio, Inc. | $5.5m | $0.76 | -1.7% | 15.5K |
 CLDI | Calidi Biotherapeutics, Inc. | $2.3m | $0.24 | +1.7% | 58.9K |